Jon Winkelried, Insider at Trevi Therapeutics, Inc. (TRVI), sold 1,000,000 shares at $2.86 ($2.9M) on 2022-07-01, disclosed to the SEC on 2022-07-06.
Open-market sale of $2.9M TRVI by Insider. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.86 | 436,431 | $1.2M | 43.2% |
| 2 | $2.86 | 436,431 | $1.2M | 43.2% |
| 3 | $3.11 | 63,569 | $198K | 6.8% |
| 4 | $3.11 | 63,569 | $198K | 6.8% |
| Total | $2.89 avg | 1,000,000 | $2.9M | 100% |
| Filing → |
| LFST | SELL | 2024-05-29 | $171.7M | — | Filing → |
| TPG | SELL | 2024-02-29 | $45.9M | — | Filing → |
| NXT | SELL | 2024-02-07 | $622.6M | — | Filing → |